The YouTuber agrees with Morningstar's 'sell' recommendation for Teradyne, noting its cyclical business tied to chip manufacturing. Despite analyst growth estimates, he highlights the company's low revenue growth (7.9% over three years) during a chip boom and high valuation (108x free cash flow). His valuation model, even with adjusted PE multiples, projects a negative 6% return, reinforcing the sell thesis.
“So I don't necessarily disagree with Morning Star on this.”